Zkusit zdarma
REGENXBIO Inc.

REGENXBIO Inc.

RGNX
Cena:
$ 6.35
-0.40 (-5.93%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
REGENXBIO Inc. (RGNX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

REGENXBIO Inc. (RGNX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

16:20 22-05-2026

REGENXBIO Inc. (RGNX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript...

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO to Participate in Upcoming Investor Conferences

16:05 18-05-2026

ROCKVILLE, Md., May 18, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will ...

REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call Transcript

REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call Transcript

20:30 14-05-2026

REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call Transcript...

REGENXBIO Advances Duchenne Gene Therapy Toward Accelerated Approval

REGENXBIO Advances Duchenne Gene Therapy Toward Accelerated Approval

12:03 14-05-2026

REGENXBIO Inc. (NASDAQ:RGNX) on Thursday released topline and interim functional data from the pivot...

Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates

Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates

9:30 14-05-2026

Regenxbio (RGNX) came out with a quarterly loss of $1.72 per share versus the Zacks Consensus Estima...

REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights

REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights

7:10 14-05-2026

Company announced positive topline results from pivotal Phase III AFFINITY DUCHENNE ® study of RGX-...

Regenxbio's muscle disorder therapy meets main goal in late-stage study

Regenxbio's muscle disorder therapy meets main goal in late-stage study

7:04 14-05-2026

Regenxbio said on Thursday that ​its experimental therapy to ‌treat a muscle-wasting disorder me...

REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202

REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202

7:00 14-05-2026

Achieved primary endpoint with high statistical significance; 93% of patients achieved microdystroph...

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting

7:05 07-05-2026

ROCKVILLE, Md., May 7, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentat...

REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy

REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy

7:05 06-05-2026

-- Company will also report first quarter 2026 financial results and operational highlights -- ROCKV...

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX

20:05 14-04-2026

LOS ANGELES, April 14, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action la...

RGNX Deadline Today: RGRX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

RGNX Deadline Today: RGRX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

14:00 14-04-2026

NEW YORK, April 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, re...

Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm

12:00 14-04-2026

New York, New York--(Newsfile Corp. - April 14, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nation...

RGNX Deadline Today: Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

RGNX Deadline Today: Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

11:45 14-04-2026

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class acti...

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of the Securities Class Action Lawsuit Deadline on April 14, 2026

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of the Securities Class Action Lawsuit Deadline on April 14, 2026

9:34 14-04-2026

NEW YORK--(BUSINESS WIRE)---- $RGNX #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie...

RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit -- The Gross Law Firm

RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit -- The Gross Law Firm

9:00 14-04-2026

NEW YORK, April 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to sharehold...

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors

9:00 14-04-2026

LOS ANGELES, April 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises REGENXBIO, Inc., (“R...

Faruqi & Faruqi, LLP Highlights Class Action Against REGENXBIO (RGNX) and Upcoming Lead Plaintiff Deadline of April 14, 2026

Faruqi & Faruqi, LLP Highlights Class Action Against REGENXBIO (RGNX) and Upcoming Lead Plaintiff Deadline of April 14, 2026

17:54 13-04-2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff...

REGENXBIO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX

REGENXBIO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX

16:13 13-04-2026

New York, New York--(Newsfile Corp. - April 13, 2026) - WHY: Rosen Law Firm, a global investor right...

Levi & Korsinsky, LLP: RGNX Disclosure Timeline Reveals Pattern of Alleged Investor Harm

Levi & Korsinsky, LLP: RGNX Disclosure Timeline Reveals Pattern of Alleged Investor Harm

15:05 13-04-2026

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP encourages investors who suffered...

close

RGNX INVESTORS HAVE OPPORTUNITY TO LEAD REGENXBIO INC. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

16-02-2026
LOS ANGELES--(BUSINESS WIRE)---- $RGNX--RGNX INVESTORS HAVE OPPORTUNITY TO LEAD REGENXBIO INC. SECUR...
Více zde

INVESTOR NOTICE: SHAREHOLDER RIGHTS LAW FIRM ROBBINS LLP INFORMS INVESTORS OF THE REGENXBIO, INC. SECURITIES CLASS ACTION LAWSUIT

16-02-2026
SAN DIEGO--(BUSINESS WIRE)---- $RGNX #BIOTECHNOLOGY--ROBBINS LLP INFORMS STOCKHOLDERS THAT A CLASS A...
Více zde

ROSEN LAW FIRM URGES REGENXBIO, INC. (NASDAQ: RGNX) STOCKHOLDERS WITH LARGE LOSSES TO CONTACT THE FIRM FOR INFORMATION ABOUT THEIR RIGHTS

16-02-2026
NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES A CLASS ACTI...
Více zde

GAINEY MCKENNA & EGLESTON ANNOUNCES A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST REGENXBIO INC. (RGNX)

16-02-2026
NEW YORK, FEB. 16, 2026 (GLOBE NEWSWIRE) -- GAINEY MCKENNA & EGLESTON ANNOUNCES THAT A SECURITIES CL...
Více zde

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IT HAS FILED A COMPLAINT TO RECOVER LOSSES SUFFERED BY PURCHASERS OF REGENXBIO INC. SECURITIES AND SETS A LEAD PLAINTIFF DEADLINE OF APRIL 14, 2026

13-02-2026
NEW YORK, FEB. 13, 2026 (GLOBE NEWSWIRE) -- THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSIN...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF REGENXBIO INC. - RGNX

12-02-2026
NEW YORK, FEB. 12, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

REGENXBIO ANNOUNCES REGULATORY UPDATE ON RGX-121 BLA FOR MPS II

09-02-2026
FDA ISSUES COMPLETE RESPONSE LETTER FOR RGX-121 (CLEMIDSOGENE LANPARVOVEC) FOR TREATMENT OF MUCOPOLY...
Více zde

ONGOING INVESTIGATION: REGENXBIO INC. (RGNX) MAY HAVE MISLED SHAREHOLDERS - LEVI & KORSINSKY INVESTIGATES

09-02-2026
NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 9, 2026) - LEVI & KORSINSKY NOTIFIES INVESTORS THAT I...
Více zde

RGNX INVESTORS HAVE OPPORTUNITY TO JOIN REGENXBIO INC. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

03-02-2026
LOS ANGELES--(BUSINESS WIRE)---- $RGNX--RGNX INVESTORS HAVE OPPORTUNITY TO JOIN REGENXBIO INC. FRAUD...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF REGENXBIO INC. - RGNX

03-02-2026
NEW YORK, FEB. 03, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

LOST MONEY ON REGENXBIO INC. (RGNX)? POSSIBLE FRAUD - CONTACT LEVI & KORSINSKY TODAY

02-02-2026
NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 2, 2026) - LEVI & KORSINSKY NOTIFIES INVESTORS THAT I...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF REGENXBIO INC. - RGNX

29-01-2026
NEW YORK, JAN. 29, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS...
Více zde

INVESTIGATION INTO REGENXBIO: QUESTIONS ARISE OVER DISCLOSURE COMPLETENESS PRIOR TO FDA ACTION

29-01-2026
(NASDAQ: RGNX) NEW YORK, JAN. 29, 2026 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP IS INVESTIGATING REGENX...
Více zde

RGNX ALERT: LEVI & KORSINSKY INVESTIGATES REGENXBIO INC. FOR POSSIBLE SECURITIES FRAUD VIOLATIONS

29-01-2026
NEW YORK, NEW YORK--(NEWSFILE CORP. - JANUARY 29, 2026) - LEVI & KORSINSKY NOTIFIES INVESTORS THAT I...
Více zde

INVESTOR ALERT: INVESTIGATION OF REGENXBIO INC. (RGNX) BY HOLZER & HOLZER, LLC

28-01-2026
ATLANTA, JAN. 28, 2026 (GLOBE NEWSWIRE) -- HOLZER & HOLZER, LLC IS INVESTIGATING WHETHER REGENXBIO I...
Více zde

REGENXBIO ANNOUNCES REGULATORY UPDATE ON ULTRA RARE MPS PROGRAMS

28-01-2026
ROCKVILLE, MD., JAN. 28, 2026 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED THAT TH...
Více zde

REGENXBIO HIGHLIGHTS KEY 2026 CATALYSTS AND ANNOUNCES POSITIVE LONG-TERM FUNCTIONAL OUTCOMES IN LEAD DUCHENNE GENE THERAPY PROGRAM

11-01-2026
NEW PHASE I/II RGX-202 FUNCTIONAL DATA DEMONSTRATES LONG-TERM, DURABLE TREATMENT EFFECT AT PIVOTAL D...
Více zde

REGENXBIO TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

18-12-2025
ROCKVILLE, MD. , DEC. 18, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED IT WILL...
Více zde

REGENXBIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE

25-11-2025
ROCKVILLE, MD. , NOV. 25, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED IT WILL...
Více zde

REGENXBIO REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

06-11-2025
RGX-202 PROGRAM FOR DUCHENNE MUSCULAR DYSTROPHY ADVANCING RAPIDLY, TOPLINE RESULTS EXPECTED EARLY Q...
Více zde

REGENXBIO ANNOUNCES COMPLETION OF PIVOTAL ENROLLMENT AND INITIATES COMMERCIAL PRODUCTION IN DUCHENNE GENE THERAPY PROGRAM

30-10-2025
PATIENTS TREATED WITH RGX-202 DEMONSTRATE CONSISTENT, ROBUST MICRODYSTROPHIN EXPRESSION AND FUNCTIO...
Více zde

REGENXBIO TO HOST CONFERENCE CALL ON NOVEMBER 6 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

29-10-2025
ROCKVILLE, MD. , OCT. 29, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED THAT IT...
Více zde

REGENXBIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

15-10-2025
ROCKVILLE, MD. , OCT. 15, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED IT WILL...
Více zde

REGENXBIO ANNOUNCES PRESENTATION AT THE AMERICAN ACADEMY OF OPHTHALMOLOGY 2025 ANNUAL MEETING

09-10-2025
ROCKVILLE, MD. , OCT. 9, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED THAT IT ...
Více zde

REGENXBIO ANNOUNCES COMPLETION OF ENROLLMENT IN PIVOTAL TRIALS OF SUBRETINAL SURABGENE LOMPARVOVEC FOR WET AMD

06-10-2025
OVER 1,200 PARTICIPANTS ENROLLED IN ATMOSPHERE® AND ASCENT® PIVOTAL TRIALS, REPRESENTING LARGEST G...
Více zde

REGENXBIO ANNOUNCES PRESENTATION AT THE WORLD MUSCLE SOCIETY

29-09-2025
ROCKVILLE, MD. , SEPT. 29, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED CHIEF ...
Více zde

REGENXBIO PRESENTS POSITIVE TWELVE-MONTH PIVOTAL DATA FROM PHASE I/II/III CAMPSIITE® TRIAL OF RGX-121 FOR TREATMENT OF MPS II

05-09-2025
12-MONTH PIVOTAL DATA FURTHER DEMONSTRATE THE ABILITY OF ONE-TIME RGX-121 TREATMENT TO IMPROVE OUTCO...
Více zde

REGENXBIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

28-08-2025
ROCKVILLE, MD. , AUG. 28, 2025 /PRNEWSWIRE/ -- REGENXBIO INC. (NASDAQ: RGNX) TODAY ANNOUNCED IT WILL...
Více zde

REGENXBIO ANNOUNCES FDA REVIEW EXTENSION OF BLA FOR RGX-121 TO TREAT PATIENTS WITH MPS II

18-08-2025
RGX-121 WOULD BE THE FIRST AND ONLY POTENTIAL ONE-TIME COMMERCIALLY-AVAILABLE THERAPY DESIGNED TO DI...
Více zde

REGENXBIO REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

07-08-2025
RGX-202 IN DUCHENNE MUSCULAR DYSTROPHY ON TRACK FOR TOPLINE RESULTS 1H 2026 AND BLA SUBMISSION MID-2...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-10 00:00:008-KStáhnout
2026-01-28 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-08-18 01:00:008-KStáhnout
2025-08-18 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-05-19 01:00:008-KStáhnout
2025-05-19 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 01:00:0010-QStáhnout
2025-05-12 00:00:008-KStáhnout
2025-05-12 00:00:0010-QStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-13 00:00:0010-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-12 23:00:0010-KStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-03 23:00:008-KStáhnout
2025-01-14 00:00:008-KStáhnout
2025-01-13 23:00:008-KStáhnout
2024-12-09 00:00:008-KStáhnout
2024-12-08 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-09-17 01:00:008-KStáhnout
2024-09-17 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-01 01:00:008-KStáhnout
2024-08-01 01:00:0010-QStáhnout
2024-08-01 00:00:008-KStáhnout
2024-08-01 00:00:0010-QStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-06-03 01:00:008-KStáhnout
2024-06-03 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-03-11 00:00:008-KStáhnout
2024-03-10 23:00:008-KStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-09-01 01:00:008-KStáhnout
2023-09-01 00:00:008-KStáhnout
2023-08-02 01:00:008-KStáhnout
2023-08-02 01:00:0010-QStáhnout
2023-08-02 00:00:008-KStáhnout
2023-08-02 00:00:0010-QStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-03 01:00:008-KStáhnout
2023-05-03 01:00:0010-QStáhnout
2023-05-03 00:00:008-KStáhnout
2023-05-03 00:00:0010-QStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2023-01-10 00:00:008-KStáhnout
2023-01-09 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:008-KStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-06-07 01:00:008-KStáhnout
2022-06-07 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-03-25 00:00:008-KStáhnout
2022-03-24 23:00:008-KStáhnout
2022-03-18 00:00:008-KStáhnout
2022-03-17 23:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-02-14 00:00:008-KStáhnout
2022-02-13 23:00:008-KStáhnout
2022-02-09 00:00:008-KStáhnout
2022-02-08 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-11 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-02 00:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:008-KStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-10-01 01:00:008-KStáhnout
2021-10-01 00:00:008-KStáhnout
2021-09-13 01:00:008-KStáhnout
2021-09-13 00:00:008-KStáhnout
2021-09-07 01:00:008-KStáhnout
2021-09-07 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-07-16 01:00:008-KStáhnout
2021-07-16 00:00:008-KStáhnout
2021-06-07 01:00:008-KStáhnout
2021-06-07 00:00:008-KStáhnout
2021-05-05 01:00:008-KStáhnout
2021-05-05 01:00:0010-QStáhnout
2021-05-05 00:00:008-KStáhnout
2021-05-05 00:00:0010-QStáhnout
2021-03-01 00:00:008-KStáhnout
2021-03-01 00:00:0010-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-28 23:00:0010-KStáhnout
2021-01-08 00:00:008-KStáhnout
2021-01-07 23:00:008-KStáhnout
2021-01-05 00:00:008-KStáhnout
2021-01-04 23:00:008-KStáhnout
2020-12-22 00:00:008-KStáhnout
2020-12-21 23:00:008-KStáhnout
2020-11-04 00:00:008-KStáhnout
2020-11-04 00:00:0010-QStáhnout
2020-11-03 23:00:008-KStáhnout
2020-11-03 23:00:0010-QStáhnout
2020-10-27 00:00:008-KStáhnout
2020-10-26 23:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-07-02 01:00:008-KStáhnout
2020-07-02 00:00:008-KStáhnout
2020-06-01 01:00:008-KStáhnout
2020-06-01 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-26 00:00:0010-KStáhnout
2020-02-25 23:00:008-KStáhnout
2020-02-25 23:00:0010-KStáhnout
2020-01-09 00:00:008-KStáhnout
2020-01-08 23:00:008-KStáhnout
2019-11-05 00:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:008-KStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-10-15 01:00:008-KStáhnout
2019-10-15 00:00:008-KStáhnout
2019-08-07 01:00:008-KStáhnout
2019-08-07 01:00:0010-QStáhnout
2019-08-07 00:00:008-KStáhnout
2019-08-07 00:00:0010-QStáhnout
2019-06-03 01:00:008-KStáhnout
2019-06-03 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-02-27 00:00:008-KStáhnout
2019-02-27 00:00:0010-KStáhnout
2019-02-26 23:00:008-KStáhnout
2019-02-26 23:00:0010-KStáhnout
2019-01-03 00:00:008-KStáhnout
2019-01-02 23:00:008-KStáhnout
2018-11-07 00:00:008-KStáhnout
2018-11-07 00:00:0010-QStáhnout
2018-11-06 23:00:008-KStáhnout
2018-11-06 23:00:0010-QStáhnout
2018-11-06 00:00:008-KStáhnout
2018-11-05 23:00:008-KStáhnout
2018-10-29 00:00:008-KStáhnout
2018-10-28 23:00:008-KStáhnout
2018-08-10 01:00:008-KStáhnout
2018-08-10 00:00:008-KStáhnout
2018-08-08 01:00:008-KStáhnout
2018-08-08 01:00:0010-QStáhnout
2018-08-08 00:00:008-KStáhnout
2018-08-08 00:00:0010-QStáhnout
2018-06-11 01:00:008-KStáhnout
2018-06-11 00:00:008-KStáhnout
2018-05-29 01:00:008-KStáhnout
2018-05-29 00:00:008-KStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 01:00:0010-QStáhnout
2018-05-08 00:00:008-KStáhnout
2018-05-08 00:00:0010-QStáhnout
2018-03-06 00:00:008-KStáhnout
2018-03-06 00:00:0010-KStáhnout
2018-03-05 23:00:008-KStáhnout
2018-03-05 23:00:0010-KStáhnout
2018-01-11 00:00:008-KStáhnout
2018-01-10 23:00:008-KStáhnout
2018-01-09 00:00:008-KStáhnout
2018-01-08 23:00:008-KStáhnout
2018-01-04 00:00:008-KStáhnout
2018-01-03 23:00:008-KStáhnout
2017-11-08 00:00:008-KStáhnout
2017-11-08 00:00:0010-QStáhnout
2017-11-07 23:00:008-KStáhnout
2017-11-07 23:00:0010-QStáhnout
2017-10-03 01:00:008-KStáhnout
2017-10-03 00:00:008-KStáhnout
2017-08-25 01:00:008-KStáhnout
2017-08-25 00:00:008-KStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-05-25 01:00:008-KStáhnout
2017-05-25 00:00:008-KStáhnout
2017-05-09 01:00:008-KStáhnout
2017-05-09 01:00:0010-QStáhnout
2017-05-09 00:00:008-KStáhnout
2017-05-09 00:00:0010-QStáhnout
2017-04-26 01:00:008-KStáhnout
2017-04-26 00:00:008-KStáhnout
2017-03-24 00:00:008-KStáhnout
2017-03-23 23:00:008-KStáhnout
2017-03-07 00:00:008-KStáhnout
2017-03-07 00:00:0010-KStáhnout
2017-03-06 23:00:008-KStáhnout
2017-03-06 23:00:0010-KStáhnout
2017-01-06 00:00:008-KStáhnout
2017-01-05 23:00:008-KStáhnout
2016-11-09 00:00:008-KStáhnout
2016-11-09 00:00:0010-QStáhnout
2016-11-08 23:00:008-KStáhnout
2016-11-08 23:00:0010-QStáhnout
2016-09-12 01:00:008-KStáhnout
2016-09-12 00:00:008-KStáhnout
2016-08-16 01:00:008-KStáhnout
2016-08-16 00:00:008-KStáhnout
2016-08-09 01:00:008-KStáhnout
2016-08-09 01:00:0010-QStáhnout
2016-08-09 00:00:008-KStáhnout
2016-08-09 00:00:0010-QStáhnout
2016-08-02 01:00:008-KStáhnout
2016-08-02 00:00:008-KStáhnout
2016-07-05 01:00:008-KStáhnout
2016-07-05 00:00:008-KStáhnout
2016-06-01 01:00:008-KStáhnout
2016-06-01 00:00:008-KStáhnout
2016-05-05 01:00:008-KStáhnout
2016-05-05 01:00:0010-QStáhnout
2016-05-05 00:00:008-KStáhnout
2016-05-05 00:00:0010-QStáhnout
2016-04-19 01:00:008-KStáhnout
2016-04-19 00:00:008-KStáhnout
2016-03-03 00:00:008-KStáhnout
2016-03-03 00:00:0010-KStáhnout
2016-03-02 23:00:008-KStáhnout
2016-03-02 23:00:0010-KStáhnout
2016-01-07 00:00:008-KStáhnout
2016-01-06 23:00:008-KStáhnout
2015-12-30 00:00:008-KStáhnout
2015-12-29 23:00:008-KStáhnout
2015-11-05 00:00:008-KStáhnout
2015-11-05 00:00:0010-QStáhnout
2015-11-04 23:00:008-KStáhnout
2015-11-04 23:00:0010-QStáhnout
2015-10-15 01:00:008-KStáhnout
2015-10-15 00:00:008-KStáhnout
2015-10-01 01:00:008-KStáhnout
2015-10-01 00:00:008-KStáhnout
2015-09-22 01:00:008-KStáhnout
2015-09-22 00:00:008-KStáhnout
preloader